vs

Side-by-side financial comparison of DMC Global Inc. (BOOM) and Orthofix Medical Inc. (OFIX). Click either name above to swap in a different company.

Orthofix Medical Inc. is the larger business by last-quarter revenue ($219.9M vs $143.5M, roughly 1.5× DMC Global Inc.). Orthofix Medical Inc. runs the higher net margin — -1.0% vs -7.8%, a 6.8% gap on every dollar of revenue. On growth, Orthofix Medical Inc. posted the faster year-over-year revenue change (2.0% vs -5.8%). Orthofix Medical Inc. produced more free cash flow last quarter ($16.8M vs $9.6M). Over the past eight quarters, Orthofix Medical Inc.'s revenue compounded faster (8.0% CAGR vs -7.3%).

DMC Mining Services is a mining services contractor founded in 1980 operating in Canada, the United States, Chile, and Mongolia

Orthofix Medical Inc. is a global medical device firm specializing in orthopedic care. It develops, manufactures and sells spinal implants, trauma care products, bone growth stimulation therapies and regenerative medicine offerings, serving orthopedic surgeons and healthcare providers across North America, Europe and Asia Pacific.

BOOM vs OFIX — Head-to-Head

Bigger by revenue
OFIX
OFIX
1.5× larger
OFIX
$219.9M
$143.5M
BOOM
Growing faster (revenue YoY)
OFIX
OFIX
+7.8% gap
OFIX
2.0%
-5.8%
BOOM
Higher net margin
OFIX
OFIX
6.8% more per $
OFIX
-1.0%
-7.8%
BOOM
More free cash flow
OFIX
OFIX
$7.2M more FCF
OFIX
$16.8M
$9.6M
BOOM
Faster 2-yr revenue CAGR
OFIX
OFIX
Annualised
OFIX
8.0%
-7.3%
BOOM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BOOM
BOOM
OFIX
OFIX
Revenue
$143.5M
$219.9M
Net Profit
$-11.2M
$-2.2M
Gross Margin
17.1%
71.1%
Operating Margin
-7.8%
0.2%
Net Margin
-7.8%
-1.0%
Revenue YoY
-5.8%
2.0%
Net Profit YoY
-3871.6%
92.4%
EPS (diluted)
$-0.60
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BOOM
BOOM
OFIX
OFIX
Q4 25
$143.5M
$219.9M
Q3 25
$151.5M
$205.6M
Q2 25
$155.5M
$203.1M
Q1 25
$159.3M
$193.6M
Q4 24
$152.4M
$215.7M
Q3 24
$152.4M
$196.6M
Q2 24
$171.2M
$198.6M
Q1 24
$166.9M
$188.6M
Net Profit
BOOM
BOOM
OFIX
OFIX
Q4 25
$-11.2M
$-2.2M
Q3 25
$-3.1M
$-22.8M
Q2 25
$116.0K
$-14.1M
Q1 25
$677.0K
$-53.1M
Q4 24
$296.0K
$-29.1M
Q3 24
$-101.3M
$-27.4M
Q2 24
$4.0M
$-33.4M
Q1 24
$2.6M
$-36.0M
Gross Margin
BOOM
BOOM
OFIX
OFIX
Q4 25
17.1%
71.1%
Q3 25
21.7%
72.2%
Q2 25
23.6%
68.7%
Q1 25
25.9%
62.8%
Q4 24
20.8%
69.0%
Q3 24
19.8%
68.7%
Q2 24
27.1%
67.8%
Q1 24
25.4%
67.5%
Operating Margin
BOOM
BOOM
OFIX
OFIX
Q4 25
-7.8%
0.2%
Q3 25
0.4%
-8.3%
Q2 25
2.5%
-7.9%
Q1 25
4.1%
-25.2%
Q4 24
-0.5%
-5.3%
Q3 24
-97.7%
-9.6%
Q2 24
6.8%
-12.5%
Q1 24
4.0%
-15.6%
Net Margin
BOOM
BOOM
OFIX
OFIX
Q4 25
-7.8%
-1.0%
Q3 25
-2.0%
-11.1%
Q2 25
0.1%
-6.9%
Q1 25
0.4%
-27.4%
Q4 24
0.2%
-13.5%
Q3 24
-66.5%
-13.9%
Q2 24
2.3%
-16.8%
Q1 24
1.5%
-19.1%
EPS (diluted)
BOOM
BOOM
OFIX
OFIX
Q4 25
$-0.60
$-0.05
Q3 25
$-0.10
$-0.57
Q2 25
$-0.24
$-0.36
Q1 25
$0.04
$-1.35
Q4 24
$-0.18
$-0.76
Q3 24
$-8.27
$-0.71
Q2 24
$0.24
$-0.88
Q1 24
$0.01
$-0.95

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BOOM
BOOM
OFIX
OFIX
Cash + ST InvestmentsLiquidity on hand
$31.9M
$82.0M
Total DebtLower is stronger
$50.6M
Stockholders' EquityBook value
$242.1M
$450.0M
Total Assets
$635.8M
$850.6M
Debt / EquityLower = less leverage
0.21×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BOOM
BOOM
OFIX
OFIX
Q4 25
$31.9M
$82.0M
Q3 25
$26.4M
$62.9M
Q2 25
$12.4M
$65.6M
Q1 25
$14.7M
$58.0M
Q4 24
$14.3M
$83.2M
Q3 24
$14.5M
$30.1M
Q2 24
$14.6M
$26.4M
Q1 24
$20.4M
$27.0M
Total Debt
BOOM
BOOM
OFIX
OFIX
Q4 25
$50.6M
Q3 25
$56.5M
$157.2M
Q2 25
$58.7M
$157.0M
Q1 25
$72.4M
$156.9M
Q4 24
$70.8M
$157.0M
Q3 24
$74.2M
$118.5M
Q2 24
$84.1M
$118.0M
Q1 24
$88.0M
$118.2M
Stockholders' Equity
BOOM
BOOM
OFIX
OFIX
Q4 25
$242.1M
$450.0M
Q3 25
$253.0M
$442.5M
Q2 25
$253.9M
$458.3M
Q1 25
$253.9M
$458.3M
Q4 24
$251.0M
$503.1M
Q3 24
$256.5M
$525.9M
Q2 24
$416.0M
$546.0M
Q1 24
$409.9M
$570.3M
Total Assets
BOOM
BOOM
OFIX
OFIX
Q4 25
$635.8M
$850.6M
Q3 25
$644.1M
$832.6M
Q2 25
$645.0M
$837.2M
Q1 25
$670.6M
$823.1M
Q4 24
$671.3M
$893.3M
Q3 24
$702.0M
$867.9M
Q2 24
$869.5M
$882.0M
Q1 24
$860.0M
$906.0M
Debt / Equity
BOOM
BOOM
OFIX
OFIX
Q4 25
0.21×
Q3 25
0.22×
0.36×
Q2 25
0.23×
0.34×
Q1 25
0.29×
0.34×
Q4 24
0.28×
0.31×
Q3 24
0.29×
0.23×
Q2 24
0.20×
0.22×
Q1 24
0.21×
0.21×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BOOM
BOOM
OFIX
OFIX
Operating Cash FlowLast quarter
$15.2M
$27.7M
Free Cash FlowOCF − Capex
$9.6M
$16.8M
FCF MarginFCF / Revenue
6.7%
7.6%
Capex IntensityCapex / Revenue
3.9%
4.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$37.0M
$-1.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BOOM
BOOM
OFIX
OFIX
Q4 25
$15.2M
$27.7M
Q3 25
$18.6M
$12.4M
Q2 25
$15.2M
$11.6M
Q1 25
$4.5M
$-18.4M
Q4 24
$11.8M
$23.7M
Q3 24
$19.0M
$11.7M
Q2 24
$2.3M
$9.0M
Q1 24
$13.4M
$-18.6M
Free Cash Flow
BOOM
BOOM
OFIX
OFIX
Q4 25
$9.6M
$16.8M
Q3 25
$14.4M
$2.5M
Q2 25
$12.3M
$4.5M
Q1 25
$709.0K
$-25.1M
Q4 24
$6.1M
$15.2M
Q3 24
$12.9M
$6.3M
Q2 24
$-204.0K
$-360.0K
Q1 24
$10.5M
$-29.1M
FCF Margin
BOOM
BOOM
OFIX
OFIX
Q4 25
6.7%
7.6%
Q3 25
9.5%
1.2%
Q2 25
7.9%
2.2%
Q1 25
0.4%
-13.0%
Q4 24
4.0%
7.0%
Q3 24
8.5%
3.2%
Q2 24
-0.1%
-0.2%
Q1 24
6.3%
-15.4%
Capex Intensity
BOOM
BOOM
OFIX
OFIX
Q4 25
3.9%
4.9%
Q3 25
2.8%
4.8%
Q2 25
1.9%
3.5%
Q1 25
2.4%
3.5%
Q4 24
3.7%
4.0%
Q3 24
4.0%
2.7%
Q2 24
1.5%
4.7%
Q1 24
1.8%
5.6%
Cash Conversion
BOOM
BOOM
OFIX
OFIX
Q4 25
Q3 25
Q2 25
131.43×
Q1 25
6.63×
Q4 24
39.90×
Q3 24
Q2 24
0.58×
Q1 24
5.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BOOM
BOOM

Dyna Energetics Segment$68.9M48%
Other$57.0M40%
Nobel Clad Segment$17.7M12%

OFIX
OFIX

Spinal Implants Biologics And Enabling Technologies$113.6M52%
Bone Growth Therapies$68.3M31%
Other$22.7M10%
IT$5.9M3%
GB$3.5M2%
FR$3.5M2%
DE$2.3M1%

Related Comparisons